Armored macrophage-targeted CAR-T cells reset and reprogram the tumor microenvironment and control metastatic cancer growth.
In a significant departure from traditional oncology approaches, researchers at the Icahn School of Medicine...
Knowledge and News for the Global Fight Against Cancer.
In a significant departure from traditional oncology approaches, researchers at the Icahn School of Medicine...
Singapore – Scientists at Duke-NUS Medical School have identified a pivotal molecular switch that governs...
The biological landscape of gynecological oncology has long been haunted by the aggressive and elusive...
The medical journey of two-year-old Lily, a child twice diagnosed with neuroblastoma, serves as a...
The landscape of pediatric neuro-oncology is witnessing a significant shift as a groundbreaking clinical trial...
Memorial Sloan Kettering Cancer Center researcher Kathryn Taylor, PhD, has been named the latest recipient...
A kidney cancer diagnosis, historically a harbinger of profound uncertainty and fear, is increasingly met...
In a significant advance for cancer research, scientists at the Sloan Kettering Institute (SKI) at...
The conventional arsenal against cancer, including chemotherapy and radiation, primarily functions by attacking rapidly dividing...
New research from the University of Virginia (UVA) Health’s Beirne B. Carter Center for Immunology...